April 20, 2017, Coralville, IA. – We are pleased to announce that the National Institutes of Health (NIH) has selected Emmyon to exhibit and showcase its technology at the 2017 BIO International Convention, which will be held in San Diego, CA from June 19-22, 2017. Emmyon will be located within the NIH’s Innovation Zone. We’re honored and excited to participate as an NIH-sponsored company at the world’s largest biotechnology conference and exhibition.
Dr. John Talley named one of world’s 100 most influential people in drug discovery and development
September 1, 2016, Coralville, IA. – Emmyon is delighted to announce that its Senior Scientific Advisor, Dr. John Talley, has been named, for the second year in a row, to the highly prestigious Power List of The Medicine Maker magazine. In the 2016 Power List, Dr. Talley was named as the world’s 17th most influential person in drug discovery and development.
Emmyon receives Phase I SBIR award from the National Institutes of Health
April 1, 2016, Coralville, IA – Emmyon is pleased to announce that it has received a new Phase I SBIR award from the National Institutes of Health. The funding will support development of pharmaceuticals for skeletal muscle atrophy and weakness.
Emmyon scientists discover fundamental molecular mechanism of skeletal muscle atrophy
August 19, 2016, Coralville, IA – In collaboration with colleagues at the University of Iowa and the Buck Institute for Research on Aging, Emmyon scientists Chris Adams, Scott Ebert and Mike Dyle published a new paper today describing a previously unknown mechanism of skeletal muscle atrophy.
The paper, entitled “Gadd45a promotes skeletal muscle atrophy by forming a complex with the protein kinase MEKK4” was published in The Journal of Biological Chemistry. The paper was selected as a JBC Paper of the Week and was selected for the journal cover. To view the paper, please click here.
Emmyon scientists discover small molecules that reduce muscle loss and weakness during aging
September 3, 2015, Coralville, IA. – Emmyon scientists Scott Ebert, John Talley and Christopher Adams published a new paper today describing ursolic acid and tomatidine as natural compounds that reduce muscle loss and weakness during aging. The paper, published in The Journal of Biological Chemistry, may be found here.
Emmyon research covered in Chemical and Engineering News
September 21, 2015, Washington D.C. – Emmyon research was featured today in Chemical and Engineering News, a publication of the American Chemical Society. The article, “Chemical Fountain of Youth Explained,” may be found below:
